Our group has shown many years ago the prognostic significance of CK-19 mRNA detection in peripheral blood of early breast cancer patients, using 20 mL of peripheral blood for CTC isolation and further downstream analysis [36,38]. This evidence concerns the gene KRT19 and breast cancer.